3-Methyl-4- (3-methyl-4-oxo-2,4,5,6,7,8-hexahydrocyclohepta[c]pyrrol-1-yl) benzamide
Selected Variant
HY-170219
Size: 1 Each
RMM23 is an inhibitor targeting PfBDP1 with a Kd value of 1.24 μM. RMM23 against the wild-type strains 3D7 and NF54, and the multidrug-resistant K1 strain in vitro blood stage, with EC50 values of 18 μM, 14 μM, 20 μM, respectively [1].
Product Specifications
UNSPSC
12352005
Target
Epigenetic Reader Domain; Parasite
Related Pathways
Anti-infection; Epigenetics
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
CC1=C2C(CCCCC2=C(C3=CC=C(C(N)=O)C=C3C)N1)=O
Molecular Formula
C18H20N2O2
Molecular Weight
296.36
References & Citations
[1]Marius Amann, et al. A Novel Inhibitor against the Bromodomain Protein 1 of the Malaria Pathogen Plasmodium Falciparum. ChemMedChem. 2025 Mar 18:e2500024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog